Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Transplant. Sep 18, 2023; 13(5): 276-289
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Table 1 Definitions of terms used to describe the living donors at different stages of kidney donation including access, counseling, evaluation, acceptance, candidacy, and donation with kidney transplantation of related intended patients
Term
Definition
PLDAn individual who confirmed his willingness to donate a kidney to an intended patient at the initial counseling settings and was ready to start the evaluation for kidney donation, regardless of the commencement of the evaluation
Related PLDPLD who had a relative intended patient with end-stage renal disease up to the 4th degree of genetic relatedness. Regardless of their genetic relatedness, the wife or husband of a recipient was considered a related PLD
Excluded PLDPLD who was disqualified as a kidney donor and excluded from the process of kidney donation by KT team due to causes that disqualify candidacy to donate a kidney, such as medical, immunological, or financial causes
Regressed PLDPLD who withdrew his decision of kidney donation at any stage after an initial confirmation of the donation decision and before the operation
Released PLD1PLD who was still willing and completed or was still continuing the evaluation, but the related intended patient was withdrawn from KT preparation due to any cause
Candidate PLDPLD who completed all the steps of evaluation and was finally accepted by the KT team for kidney donation, regardless of the later regression or release from donation
Accepted PLDPLD who completed the evaluation without exclusion from kidney donation and was accepted for donation without release or regression from his willingness
LDPLD becomes a LD when he succeeds in donating a kidney to his/her intended patient, which also means KT was achieved
Relatedness degrees and forms2First degree: father, mother, son, daughter, wife, and husband. Second degree: brother, sister, grandfather, grandmother, grandson, and granddaughter. Third degree: nephew, uncle and aunt. Fourth degree: cousins
Table 2 Demographic and clinical characteristics of patients and related potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors
Characteristics
Total patients, n = 212
Patients with candidate PLDs, n = 74
Patients with non-candidate PLDs, n = 138
P value
mean ± SD (range)/number (%)
Mean age in yr31.2 ± 10.6 (13-66)29.1 ± 9.6 (13-57)32.9 ± 12.0 (14-66)0.041
Sex, n = 212
Males173 (81.6%)67 (90.5%)106 (76.8%)0.087
Females39 (18.4%)7 (9.5%)32 (23.2%)
Status of dialysis at presentation, n = 212
Preemptive19 (9.0%)5 (6.8%)14 (10.1%)0.462
On regular hemodialysis193 (91.0%)69 (93.2%)124 (89.9%)
Primary kidney disease, n = 212
Unknown167 (78.8%)56 (75.7%)111 (80.4%)0.088
Systemic disease14 (6.6%)3 (2.7%)11 (8.0%)
Glomerulonephritis6 (2.8%)3 (4.0%)3 (2.2%)
Hereditary renal disease5 (3.8%)2 (2.7%)3 (2.2%)
Obstructive uropathy11 (5.2%)8 (10.8%)3 (2.2%)
Urolithiasis9 (4.2%)2 (2.7%)7 (5.1%)
Categories of primary kidney disease, n = 212
Unknown167 (78.8%)56 (75.7%)111 (80.4%)0.154
Systemic disease14 (6.6%)3 (4.0%)11 (8.0%)
Local, renal/urinary31 (14.6%)15 (20.3%)16 (11.6%)
Patients per number of PLDs, n = 212
Patients with one PLD165 (77.8%)53 (71.6%)112 (81.2%)0.265
Patients with two PLDs39 (18.4%)17 (23.0%)22 (15.9%)
Patients with three PLDs8 (3.8%)4 (5.4%)4 (2.9%)
Table 3 Patient characteristics distributed per extent and outcome of evaluation of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
Characteristics
Total patients, n = 212
Patients with candidate PLDs, n = 74
Patients with non-candidate PLDs, n = 138
P value
mean ± SD (range)/number (%)
Patients per extent of evaluation of their PLDs1, n = 212
Completed 171 (33.5%)54 (73%)17 (12.3%)< 0.001
Completed 1/incomplete 115 (7.1%)7 (9.5%)8 (5.8%)
Completed 1/incomplete 22 (0.9%)2 (2.7%)0 (0%)
Completed 1/not evaluated 17 (3.3%)6 (8.1%)1 (0.7%)
Completed 23 (1.4%)3 (4.1%)0 (0%)
Completed 2/incomplete 11 (0.5%)0 (0%)1 (0.7%)
Completed 32 (0.9%)2 (2.7%)0 (0%)
Incomplete 194 (44.3%)0 (0%)94 (68.1%)
Incomplete 1/not evaluated 11 (0.5%)0 (0%)1 (0.7%)
Incomplete 1/not evaluated 21 (0.5%)0 (0%)1 (0.7%)
Incomplete 213 (6.1%)0 (0%)13 (9.4%)
Incomplete 32 (0.9%)0 (0%)2 (1.5%)
Patients per acceptance of their PLDs1, n = 212
Accepted 144 (20.6%)44 (59.5%)0 (0%)< 0.001
Accepted 1/excluded 18 (3.8%)8 (10.8%)0 (0%)
Accepted 1/excluded 22 (0.9%)2 (2.7%)0 (0%)
Accepted 1/not evaluated 14 (1.9%)4 (5.4%)0 (0%)
Excluded 181 (38.2%)0 (0%)81 (0%)
Excluded 214 (6.6%)0 (0%)14 (10.1%)
Excluded 32 (0.9%)0 (0%)2 (1.5%)
Excluded 1/released 15 (2.4%)1 (1.4%)4 (2.9%)
Excluded 1/regressed 13 (1.4%)1 (1.4%)2 (1.5%)
Excluded 1/not evaluated 12 (0.9%)0 (0%)2 (1.5%)
Excluded 1/not evaluated 21 (0.5%)0 (0%)1 (0.7%)
Excluded 2/released 12 (0.9%)1 (1.4%)1 (0.7%)
Excluded 2/regressed 11 (0.5%)1 (1.4%)0 (0%)
Released 128 (13.2%)7 (9.5%)21 (15.2%)
Released 1/not evaluated 12 (0.9%)2 (2.7%)0 (0%)
Regressed 112 (5.7%)3 (4.1%)9 (6.5%)
Regressed 21 (0.5%)0 (0%)1 (0.7%)
Table 4 Patients distributed per characteristics of exclusion of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
Characteristics
Total patients, n = 212
Patients with candidate PLDs, n = 74
Patients with non-candidate PLDs, n = 138
P value
mean ± SD (range)/number (%)
Patients per number of excluded PLDs, n = 121
Patients with one excluded PLD100 (82.6%)10 (71.4%)90 (84.1%)0.764
Patients with two excluded PLDs19 (15.7%)4 (28.6%)15 (14.0%)
Patients with three excluded PLDs2 (1.7%)0 (0%)2 (1.9%)
Patients per causes of exclusion of their PLDs, n = 1211
Combined immunological and medical causes14 (11.6%)3 (21.4%)11 (10.3%)0.680
HLA-incompatibility24 (19.8%)3 (21.4%)21 (19.6%)
ABO-incompatibility20 (16.5%)1 (7.1%)19 (17.8%)
ABO and HLA-incompatibility2 (1.7%)0 (0%)2 (1.9%)
Age8 (6.6%)0 (0%)8 (7.5%)
Diabetes mellitus4 (3.3%)0 (0%)4 (3.7%)
HCV positive5 (4.1%)2 (14.3%)3 (2.8%)
Hypertension11 (9.1%)4 (28.6%)7 (6.5%)
Leprosy1 (0.8%)0 (0%)1 (0.9%)
Low GFR4 (3.3%)1 (7.1%)3 (2.8%)
High potential recurrence of primary kidney disease6 (5.0%)0 (0%)6 (5.6%)
Proteinuria12 (9.9%)0 (0%)12 (11.2%)
Psoriasis1 (0.8%)0 (0%)1 (0.9%)
Rheumatoid arthritis1 (0.8%)0 (0%)1 (0.9%)
Urolithiasis5 (4.1%)0 (0%)5 (4.7%)
Financial causes3 (2.5%)0 (0%)3 (2.8%)
Patients per main category of causes of exclusion of their PLDs, n = 121
Combined immunological and medical causes14 (11.6%)3 (21.4%)11 (10.3%)0.866
Immunologic mismatches46 (38%)4 (28.6%)42 (39.3%)
Medical causes58 (47.9%)7 (50.0%)51 (47.7%)
Financial causes3 (2.5%)0 (0%)3 (2.8%)
Patients per timing of PLDs regression, n = 18
During evaluation13 (72.2%)0 (0%)13 (100.0%)NA
After evaluation5 (27.8%)5 (100.0%)0 (0%)
Patients per cause of release of PLDs, n = 37
Patient death4 (10.8%)3 (27.3%)1 (3.9%)0.186
Patient regression22 (59.5%)6 (54.5%)16 (61.5%)
Patient non-candidacy11 (29.7%)2 (18.2%)9 (34.6%)
Patients per timing of release of PLDs, n = 37
During evaluation26 (70.3%)0 (0%)26 (100.0%)NA
After evaluation11 (29.7%)11 (100.0%)0 (0%)
Fate of patients with evaluated PLDs, n = 212
Transplantation in our center58 (27.4%)58 (78.4%)0 (0%)NA
Transplantation in another center14 (6.6%)1 (1.4%)13 (9.4%)0.024
On hemodialysis122 (57.6%)12 (16.2%)110 (79.7%)< 0.001
Death9 (4.2%)3 (4.1%)6 (4.4%)0.920
Unknown9 (4.2%)0 (0%)9 (6.5%)0.024
Table 5 Characteristics of potential living donors presented as total (n = 257) and as a comparison between the candidate (n = 74) and non-candidate (n = 183) groups of donors
CharacteristicsTotal PLDs, n = 257
Candidate PLDs, n = 74
Non-candidate PLDs, n = 183
P value
mean ± SD (range)/number (%)
Mean age in yr40.5 ± 10.4 (18-65)41.0 ± 10.5 (21-60)40.4 ± 10.5 (18-65)0.498
Sex
Female169 (65.8%)49 (66.2%)120 (65.6%)> 0.999
Male88 (34.2%)25 (33.8%)63 (34.4%)
Form of relatedness1
Aunt4 (1.6%)4 (5.4%)0 (0%)0.286
Brother51 (19.8%)14 (18.9%)37 (20.2%)
Cousin4 (1.6%)0 (0%)4 (2.2%)
Daughter4 (1.6%)1 (1.4%)3 (1.6%)
Father23 (8.9%)7 (9.5%)16 (8.7%)
Husband6 (2.3%)2 (2.7%)4 (2.2%)
Mother76 (29.6%)23 (31.1%)53 (29%)
Nephew1 (0.4%)0 (0%)1 (0.6%)
Sister53 (20.6%)13 (17.6%)40 (21.9%)
Son4 (1.6%)1 (1.4%)3 (1.6%)
Uncle1 (0.4%)1 (1.4%)0 (0%)
Wife30 (11.7%)8 (10.8%)22 (12.0%)
Degree of relatedness
First143 (55.6%)42 (56.8%)101 (55.2%)0.020
Second104 (40.5%)27 (36.5%)77 (42.1%)
Third6 (2.3%)5 (6.8%)1 (0.6%)
Fourth4 (1.6%)0 (0%)4 (2.2%)
Extent of evaluation
Complete109 (42.4%)74 (100.0%)35 (19.1%)NA
Incomplete148 (57.6%)0 (0%)148 (80.9%)
Fate of PLDs
Donated58 (22.6%)58 (78.4%)0 (0%)NA
Excluded144 (56.0%)0 (0%)144 (78.7%)NA
Regressed218 (7.0%)5 (6.8%)13 (31.6%)
During evaluation13 (72.2%)0 (0%)13 (100.0%)NA
After evaluation5 (27.8%)5 (100%)0 (0%)
Released37 (14.4%)11 (14.9%)26 (68.4%)
Causes of donor release
Patient death4 (10.8%)3 (27.3%)1 (3.9%)0.186
Patient regression22 (59.5%)6 (54.5%)16 (61.5%)
Patient non-candidacy11 (29.7%)2 (18.2%)9 (34.6%)
Timing of PLDs release
During evaluation26 (70.3%)0 (0%)26 (100.0%)NA
After evaluation11 (29.7%)11 (100.0%)0 (0%)
Time spent in PLDs evaluation in mo2.2 ± 1.5 (0.5-6.0)4.0 ± 0.9 (1-6)1.5 ± 1.2 (0.5-5.0)< 0.001
Table 6 Multivariate logistic regression of the potential variables influencing the candidacy of potential living donors with a completed preparation
Variables
Modality
Odds ratio
P value
Dialysis statusPreemptive vs on dialysis0.66 (0.23-1.94)0.451
Number of potential donorsSingle vs multiple1.69 (0.87-3.28)0.123
Donor ageIncreasing age1.0 (0.97-1.03)0.925
Donor sexMen vs women1.02 (0.55-1.92)0.940
Relatedness degreeFirst vs more than first1.07 (0.55-2.1)0.834